Antibody-Dependent Enhancement Infection Facilitates Dengue Virus-Regulated Signaling of IL-10 Production in Monocytes

PLoS Neglected Tropical Diseases

Volumn 8, Issue 11, 2014, Pages

  Tsai, Tsung Ting ^a   Chuang, Yi Jui ^a   Lin, Yee Shin ^a,b   Chang, Chih Peng ^a   Wan, Shu Wen ^b   Lin, Sheng Hsiang ^a   Chen, Chia Ling ^c   Lin, Chiou Feng ^a,b,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE; INTERLEUKIN 10; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE SYK; SUPPRESSOR OF CYTOKINE SIGNALING 3; IL10 PROTEIN, HUMAN;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MONOCYTE; PLAQUE ASSAY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THP 1 CELL; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; DENGUE; DENGUE VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-10; MONOCYTES; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84920531519     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003320     Document Type: Article

References (93)

1. Simmons CP, Farrar JJ, Nguyen v V, Wills B, (2012) Dengue. N Engl J Med 366: 1423–1432.
2. Halstead SB, (2012) Controversies in dengue pathogenesis. Paediatr Int Child Health 32 Suppl 15–9.
3. Wan SW, Lin CF, Yeh TM, Liu CC, Liu HS, et al. (2013) Autoimmunity in dengue pathogenesis. J Formos Med Assoc 112: 3–11.
4. Figueiredo MA, Rodrigues LC, Barreto ML, Lima JW, Costa MC, et al. (2010) Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis 4: e699.
5. Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, et al. (2012) Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis 6: e1641.
6. Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, et al. (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4: e785.
7. Nguyen NM, Tran CN, Phung LK, Duong KT, Huynh Hle A, et al. (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207: 1442–1450.
8. Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, et al. (2012) Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55: 1216–1224.
9. Low JG, Sung C, Wijaya L, Wei Y, Rathore AP, et al. (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14: 706–715.
10. Murphy BR, Whitehead SS, (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29: 587–619.
11. Thomas SJ, Endy TP, (2011) Critical issues in dengue vaccine development. Curr Opin Infect Dis 24: 442–450.
12. Perera R, Kuhn RJ, (2008) Structural proteomics of dengue virus. Curr Opin Microbiol 11: 369–377.
13. Clyde K, Kyle JL, Harris E, (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80: 11418–11431.
14. Rodenhuis-Zybert IA, Wilschut J, Smit JM, (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67: 2773–2786.
15. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, et al. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3: 866–871.
16. Wan SW, Lin CF, Lu YT, Lei HY, Anderson R, et al. (2012) Endothelial cell surface expression of protein disulfide isomerase activates beta1 and beta3 integrins and facilitates dengue virus infection. J Cell Biochem 113: 1681–1691.
17. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, et al. (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197: 823–829.
18. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672–676.
19. Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM, (2005) Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79: 4557–4567.
20. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712–722.
21. Guilarde AO, Turchi MD, Siqueira JB, JrFeres VC, Rocha B, et al. (2008) Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 197: 817–824.
22. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2–9.
23. Rothman AL, (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532–543.
24. Srikiatkhachorn A, Green S, (2010) Markers of dengue disease severity. Curr Top Microbiol Immunol 338: 67–82.
25. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, et al. (2001) Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 204: 494–507.
26. Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, et al. (2012) A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg 86: 341–348.
27. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183–188.
28. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 59: 329–334.
29. Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, et al. (2012) Cellular and cytokine correlates of severe dengue infection. PLoS One 7: e50387.
30. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189: 221–232.
31. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230–234.
32. Chareonsirisuthigul T, Kalayanarooj S, Ubol S, (2007) Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88: 365–375.
33. Ubol S, Halstead SB, (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 17: 1829–1835.
34. Ubol S, Phuklia W, Kalayanarooj S, Modhiran N, (2010) Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 201: 923–935.
35. Kubo M, Hanada T, Yoshimura A, (2003) Suppressors of cytokine signaling and immunity. Nat Immunol 4: 1169–1176.
36. Malavige GN, Jeewandara C, Alles KM, Salimi M, Gomes L, et al. (2013) Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Negl Trop Dis 7: e2409.
37. Torrentes-Carvalho A, Azeredo EL, Reis SR, Miranda AS, Gandini M, et al. (2009) Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz 104: 1091–1099.
38. Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, et al. (2006) The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol 176: 2825–2832.
39. Huang WC, Tsai CC, Chen CL, Chen TY, Chen YP, et al. (2011) Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis. FASEB J 25: 3661–3673.
40. Tseng PC, Huang WC, Chen CL, Sheu BS, Shan YS, et al. (2012) Regulation of SHP2 by PTEN/AKT/GSK-3beta signaling facilitates IFN-gamma resistance in hyperproliferating gastric cancer. Immunobiology 217: 926–934.
41. Martina BE, Koraka P, Osterhaus AD, (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564–581.
42. Mayr B, Montminy M, (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599–609.
43. Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, et al. (2006) IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563–574.
44. Lin CF, Tsai CC, Huang WC, Wang CY, Tseng HC, et al. (2008) IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10. J Cell Biochem 105: 746–755.
45. Wen AY, Sakamoto KM, Miller LS, (2010) The role of the transcription factor CREB in immune function. J Immunol 185: 6413–6419.
46. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A, Avvedimento EV, (2001) cAMP signaling selectively influences Ras effectors pathways. Oncogene 20: 1186–1192.
47. Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, et al. (1994) A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem 269: 32187–32193.
48. Fang X, Yu SX, Lu Y, Bast RC, JrWoodgett JR, et al. (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A. 97: 11960–11965.
49. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA, (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785–789.
50. Chiu CT, Chuang DM, (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128: 281–304.
51. Martin M, Rehani K, Jope RS, Michalek SM, (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777–784.
52. Woodgett JR, Ohashi PS, (2005) GSK3: an in-Toll-erant protein kinase? Nat Immunol 6: 751–752.
53. Sutherland C, Leighton IA, Cohen P, (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 (Pt 1): 15–19.
54. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR, (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 21: 749–760.
55. Yost C, Torres M, Miller JR, Huang E, Kimelman D, et al. (1996) The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10: 1443–1454.
56. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, et al. (2012) The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12: 544–557.
57. Mocsai A, Ruland J, Tybulewicz VL, (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10: 387–402.
58. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771–5777.
59. Bekker LG, Maartens G, Steyn L, Kaplan G, (1998) Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis 178: 580–584.
60. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT, (2004) CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172: 4123–4132.
61. Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, et al. (2007) Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 204: 979–985.
62. Tang Y, Kou Z, Zhang F, Yao X, Liu S, et al. (2010) Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One 5: e15631.
63. Yoshimura A, Naka T, Kubo M, (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454–465.
64. Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, et al. (2006) Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203: 2461–2472.
65. Incrocci R, McCormack M, Swanson-Mungerson M, (2013) Epstein-Barr Virus LMP2A Increases IL-10 production in mitogen-stimulated primary B cells and B cell lymphomas. J Gen Virol 10.1099/vir.0.049221-0.
66. Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, et al. (2001) Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. J Infect Dis 184: 1268–1278.
67. Woitas RP, Petersen U, Moshage D, Brackmann HH, Matz B, et al. (2002) HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol 8: 562–566.
68. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170–181.
69. Reddi H, Kumar R, Jain SK, Kumar V, (2003) A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function. Virus Genes 26: 227–238.
70. Bedadala GR, Palem JR, Graham L, Hill JM, McFerrin HE, et al. (2011) Lytic HSV-1 infection induces the multifunctional transcription factor Early Growth Response-1 (EGR-1) in rabbit corneal cells. Virol J 8: 262.
71. Mayer SI, Willars GB, Nishida E, Thiel G, (2008) Elk-1, CREB, and MKP-1 regulate Egr-1 expression in gonadotropin-releasing hormone stimulated gonadotrophs. J Cell Biochem 105: 1267–1278.
72. Thiel G, Cibelli G, (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287–292.
73. Tsai YT, Chang SY, Lee CN, Kao CL, (2009) Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol 11: 604–615.
74. Ruhul Amin M, Mahbub AH, Sikder AR, Karim MM, (2010) Prediction of the post-translational modification sites on dengue virus E protein and deciphering their role in pathogenesis. Int J Bioinform Res Appl 6: 508–521.
75. Gonzalez GA, Montminy MR, (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675–680.
76. Meyer CJ, Alenghat FJ, Rim P, Fong JH, Fabry B, et al. (2000) Mechanical control of cyclic AMP signalling and gene transcription through integrins. Nat Cell Biol 2: 666–668.
77. Liu L, Cao Z, Chen J, Li R, Cao Y, et al. (2012) Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J Biol Chem 287: 11899–11910.
78. Sugimoto Y, Narumiya S, (2007) Prostaglandin E receptors. J Biol Chem 282: 11613–11617.
79. Wu WL, Ho LJ, Chang DM, Chen CH, Lai JH, (2009) Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol 39: 3413–3422.
80. Nimmerjahn F, Ravetch JV, (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34–47.
81. Takai T, (2005) Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 25: 1–18.
82. Hatton O, Lambert SL, Krams SM, Martinez OM, (2012) Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas. PLoS One 7: e42610.
83. Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, et al. (2011) Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas. J Biol Chem 286: 37368–37378.
84. Moi ML, Lim CK, Takasaki T, Kurane I, (2010) Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol 91: 103–111.
85. Dhodapkar KM, Banerjee D, Connolly J, Kukreja A, Matayeva E, et al. (2007) Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med 204: 1359–1369.
86. Chan KR, Ong EZ, Tan HC, Zhang SL, Zhang Q, et al. (2014) Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proc Natl Acad Sci U S A 111: 2722–2727.
87. Garcia-Garcia E, Rosales C, (2002) Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol 72: 1092–1108.
88. Noh KT, Son KH, Jung ID, Kang HK, Hwang SA, et al. (2012) Protein kinase C delta (PKCdelta)-extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia. J Biol Chem 287: 14226–14233.
89. Beurel E, Michalek SM, Jope RS, (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31: 24–31.
90. Park CY, Choi SH, Kang SM, Kang JI, Ahn BY, et al. (2009) Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 51: 853–864.
91. Nakayama M, Hisatsune J, Yamasaki E, Isomoto H, Kurazono H, et al. (2009) Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem 284: 1612–1619.
92. Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, et al. (2013) CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 121: 95–106.
93. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA, (2001) Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 75: 3501–3508.